Drawing from the Global Flourishing Study—which analyzed over 200,000 individuals across 23 countries—researchers found that a “dispositional forgivingness” (the general tendency to let go of grudges) is a significant predictor of multidimensional well-being.

The Biology of Bitterness

In longevity medicine, we often look at stress through the lens of the “fight or flight” response. When we harbor unforgiveness—ruminating on past hurts with resentment or hostility—our body treats that emotional state as a chronic stressor.

This state of “unforgiveness” triggers a cascade of physiological changes:

• Elevated Cortisol: Constant stress signals keep cortisol high, which can lead to weight gain, sleep disruption, and impaired immune function.

• Cardiovascular Strain: Chronic resentment is linked to higher blood pressure and heart rate, putting unnecessary wear and tear on the vascular system.

• Systemic Inflammation: Prolonged hostility increases pro-inflammatory cytokines, which are the primary drivers of aging and chronic disease.

Forgiveness as a Functional Intervention

The study highlights that forgiveness acts as an emotion-regulation strategy. By moving from a state of bitterness to one of prosocial compassion, we effectively “flip the switch” on our nervous system.

While the study found the strongest links in psychological well-being (increased optimism and purpose), it also noted subtle but important connections to physical health. Those who practiced forgiveness reported better self-rated health and higher levels of physical activity. In the world of personalized healthcare, we view forgiveness not just as a moral virtue, but as a clinical necessity for healthy aging.

Cultivating a Forgiving Disposition

How do we move toward a more forgiving state to protect our longevity? Functional medicine suggests a “whole-person” approach:

1. Regulate the Nervous System: Practices like breathwork and meditation can lower the physiological “volume” of anger, making the cognitive work of forgiveness easier.

2. The REACH Method: Many practitioners recommend the REACH framework (Recall the hurt, Empathize, Altruistic gift of forgiveness, Commit, and Hold on) as a structured way to process deep-seated resentment.

3. Community Connection: The study found that social support and a sense of belonging are closely tied to forgivingness. Strengthening your social “safety net” provides the resilience needed to let go of past offenses.

The CorAeon Perspective

At CorAeon, we believe that true longevity is about more than just the absence of disease; it is about the presence of flourishing. If you are doing the hard work of optimizing your metabolic health and preventive care, don’t let unresolved resentment be the “silent leak” in your vitality.

The data is clear: letting go is a prerequisite for moving forward. By addressing the emotional roots of stress, we create a fertile environment for our biological systems to thrive.

Ready to optimize your journey toward flourishing? Discover our holistic approach to personalized healthcare at coraeon.com.

In Health, The CorAeon Team

Mental Health Res 5, 3 (2026). https://doi.org/10.1038/s44184-026-00187-5

In a landmark multi-omic study published in Molecular Nutrition & Food Research, scientists utilized advanced metagenomics and metatranscriptomics to peer into the “transcriptional programs” of the human gut. They discovered that individuals with high adherence to a Mediterranean lifestyle don’t just have different bacteria; they have a more metabolically active “living pharmacy.” This research represents the frontier of functional medicine, shifting the focus from simply identifying which bacteria are present to understanding what those bacteria are actually doing to promote your healthspan.

One of the most provocative findings from this functional medicine practice perspective is the role of “silent flagellins.” Unlike the inflammatory proteins produced by pathogens, the beneficial bacteria enriched by a Mediterranean diet—such as Roseburia and Prevotella—produce structural proteins that communicate with your immune system without triggering a “red alert.” This subtle dialogue helps maintain gut homeostasis and has been linked to higher levels of HDL cholesterol and superior cardiovascular resilience. It is a perfect example of root cause medicine: by feeding the right microbes with polyphenols from olive oil and fiber from plants, you are essentially “tuning” your immune system to a state of calm, preventive health.

The study also highlighted a fascinating shift in the “mycobiome”—the fungal community in our gut. While individuals with lower diet adherence showed a higher richness of potentially problematic fungi like Aspergillus, those following a strict Mediterranean protocol were enriched with Yarrowia. This specific yeast, often found in high-quality olive oil, acts as a potential probiotic with antioxidant and cholesterol-lowering properties. This reinforces the CorAeon philosophy: your environment and lifestyle habits dictate your destiny, and even the “hidden” members of your microbiome are playing a role in your integrative longevity care.

Why does conventional medicine often miss these insights? Most standard panels only look at the “surface” of health—cholesterol scores or basic blood sugar. But as a specialized longevity medicine center, we investigate the deeper metabolic signatures, such as how your gut bacteria recycle nitrogen or synthesize essential proteins. The over-expression of genes related to protein synthesis and cellular mobility in the Mediterranean group suggests a “younger,” more vigorous microbial community. You can explore how we translate these complex multi-omic insights into personalized health strategies at coraeon.com.

Ultimately, your gut is a reflection of your daily choices. By choosing the fats, fibers, and phytonutrients inherent to the Mediterranean way of life, you are architecting a biological foundation that supports a longer, more vibrant life. We invite you to move beyond the standard check-up and embrace a future where your health is engineered at the molecular level. To learn more about our data-driven approach to vitality or to begin your own journey toward optimal wellness, visit us at coraeon.com today. Your microbiome is waiting for its next set of instructions.

Food & Function DOI: 10.1039/d5fo04456a

In the world of longevity medicine, we often discuss the distinction between lifespan and healthspan. While lifespan is merely the number of years you are alive, healthspan represents the duration of your life spent in optimal wellness, free from chronic disease and functional decline. To maximize this period of vitality, we must look beyond standard recommendations and embrace root cause medicine. This involves understanding how our internal biological clocks, or circadian rhythms, interact with our lifestyle habits. At CorAeon, we believe that true preventive health requires this level of granularity, moving past generic advice to build a biological strategy that works with your body, not against it.

The research, which utilized long-term Fitbit data from over 14,000 individuals, found that people who regularly exercised in the early morning were significantly less likely to develop coronary artery disease, high blood pressure, and Type 2 diabetes compared to those who exercised later in the day. Most notably, morning exercisers between 7:00 and 8:00 a.m. showed the lowest odds of coronary artery disease. These benefits were observed even when the total daily amount of physical activity was the same across groups. This suggests that “any exercise is better than none” is only the beginning of the conversation; to truly move the needle on your cardiometabolic risk, the timing of your sweat equity matters. You can learn more about how we integrate these findings into personalized protocols at coraeon.com.

As an elite functional medicine practice, we are often asked, “How can I live longer and healthier?” The answer usually lies in the synergy between different pillars of health. Why might morning exercise be so effective? It likely involves a complex interplay of hormonal regulation, improved glycemic control, and the synchronization of our metabolic processes with the rising sun. Exercising early may prime the body for better insulin sensitivity throughout the day and lead to healthier neurochemical choices. This is a hallmark of integrative longevity care: recognizing that a single habit, like a morning walk or gym session, can trigger a cascade of positive epigenetic changes that protect your heart and brain.

Standard medical panels often fail to capture these nuances, which is why CorAeon focuses on a more sophisticated diagnostic lens. We investigate the underlying drivers of inflammation and vascular health to ensure that your effort—whether in the kitchen or the gym—yields the maximum possible return. Our mission is to provide you with the answers that standard panels routinely overlook, helping you navigate the complexities of modern health with physician-led authority and evidence-backed hope.

The journey toward a longer, more vibrant life is not a sprint; it is a series of well-timed, intentional strides. By aligning your movement with your biological clock, you are participating in the very best of longevity medicine. If you are ready to stop guessing and start optimizing your path toward sustained vitality, we are here to lead the way. Discover the CorAeon difference and schedule your comprehensive evaluation by visiting coraeon.com. Your heart, and your future self, will thank you for the early start.

“Exercise Timing and Relationship with Cardiometabolic Disease,” on Sunday, March 29, at 12:30 p.m. CT / 17:30 UTC in Posters, Hall E. ACC

In the world of longevity medicine, we have long understood that all body fat is not created equal. Subcutaneous fat—the kind found just under the skin—is largely a cosmetic concern. However, visceral adipose tissue (VAT) is a metabolically active organ that secretes pro-inflammatory cytokines, driving chronic systemic inflammation. A recent landmark study has finally quantified the cost of this inflammation on the human brain. The research demonstrated that sustained visceral fat loss is directly associated with attenuated brain atrophy and improved cognitive function in late midlife. Essentially, by reducing visceral fat, you are not just shrinking your waistline; you are physically slowing the rate at which your brain shrinks.

As a leading functional medicine practice, CorAeon is dedicated to moving beyond the “sick care” model of conventional medicine. When patients ask, “How can I live longer and healthier?” they are often searching for a way to extend their healthspan—the period of life spent in optimal functional health—rather than just their lifespan. Standard medical checkups frequently miss the subclinical shifts in visceral adiposity because they rely too heavily on Body Mass Index (BMI). However, the science is clear: the link between fat and brain health is independent of total body weight. You can have a “normal” BMI and still harbor dangerous levels of visceral fat that accelerate neurodegeneration.

This is where root cause medicine becomes transformative. At CorAeon, our approach to integrative longevity care involves identifying these hidden metabolic triggers before they manifest as cognitive decline or cardiovascular disease. The study mentioned above highlights that glycemic control is a key pathway linking visceral fat to brain outcomes. By optimizing how your body processes fuel and reducing the inflammatory burden of visceral fat, we can help protect the structural integrity of your hippocampus and gray matter. You can explore our deep-dive diagnostic protocols and our philosophy on neurological preservation at coraeon.com.

Why does functional medicine succeed where conventional approaches often falter? It is because we treat the body as a single, interconnected system. We understand that your metabolic health today dictates your cognitive performance tomorrow. Our goal is to empower you with personalized, science-backed strategies that address the unique biological drivers of your aging process. Whether it is through precision nutrition, stress modulation, or targeted metabolic interventions, we focus on optimal wellness as a proactive pursuit.

The narrative of “inevitable” decline is being rewritten by the latest advances in longevity medicine. You have the power to influence your biological destiny by making informed, data-driven decisions about your health today. If you are ready to take a sophisticated, comprehensive approach to your vitality, we invite you to join us. Discover how we can help you protect your most valuable asset—your mind—by visiting us at coraeon.com to schedule your comprehensive consultation. Your future self will thank you for the intervention you start today.

Nat Commun (2026). https://doi.org/10.1038/s41467-026-71141-4

The Speculative World of “Body Replacement”

The recent headlines surrounding companies like R3 Bio and Kind Biotechnology have sparked an intense debate within the medical community. These ventures are exploring ways to use CRISPR gene-editing to “knock out” the development of the neocortex in animal and, hypothetically, human embryos. The goal is to create a living body that lacks consciousness—a biological backup that could, in theory, provide a heart, liver, or kidney whenever needed. Some even speculate on “body transplants,” where a patient’s brain is moved into a younger, cloned version of themselves to achieve a second lifespan.

While these concepts push the boundaries of biological possibility, they face gargantuan technical and ethical hurdles. Beyond the “yuck factor,” the scientific community remains deeply skeptical. There is currently no proven method to rejoin a severed spinal cord, and the risks of cloning—including severe genetic defects and premature aging—remain high. Furthermore, the ethical implications of creating a “human being who is not a human being” are profound, challenging our very definitions of personhood and medical safety.

The CorAeon Philosophy: Enhancing the Body You Have

At CorAeon, our functional medicine practice is rooted in a fundamentally different philosophy. We don’t believe in replacing the human body; we believe in optimizing it. Our approach to longevity medicine is focused on healthspan—extending the number of years you live in peak physical and cognitive condition by addressing the root cause of cellular decline.

True preventive health is not found in a laboratory-grown clone, but in the sophisticated management of your current biology. Integrative longevity care involves a deep dive into your unique biomarkers to resolve the inflammation, oxidative stress, and metabolic dysfunction that drive aging. We ask: How can we live longer and healthier today? The answer lies in personalized, science-backed protocols that stabilize arterial plaque, enhance mitochondrial function, and balance hormones.

Why Root-Cause Medicine is the Real Breakthrough

While speculative startups focus on “replacement,” CorAeon focuses on “rejuvenation.” Conventional medicine often misses the early warning signs of aging because it waits for a diagnosis to occur. Our functional medicine practice catches these signals years in advance. By identifying the triggers of disease—whether environmental, genetic, or lifestyle-based—we empower you to take your health seriously before a crisis arises.

We believe that every patient is the architect of their own vitality. You don’t need a “backup” body when you have the tools to maintain your own at an elite level. Our commitment to optimal wellness means providing you with a roadmap that is grounded in reality, safety, and the highest ethical standards.

If you are ready to explore the legitimate, science-based path to a longer life, we invite you to learn more at coraeon.com. Discover how functional medicine can help you achieve a future characterized by vitality, not just survival. The best version of you is already here—let’s help you keep it.

Learn more about our approach to life extension and health optimization at coraeon.com.

MIT Technology Review March 30, 2026

At CorAeon, our functional medicine practice is dedicated to identifying these science-backed, root-cause medicine interventions. We believe that true healthspan—the period of life spent in optimal wellness—is achieved by maintaining the integrity of our internal biological systems. The latest research indicates that the periodic, controlled removal of a small amount of blood may actually trigger a systemic “reset,” revitalizing your bone marrow and clearing out the molecular debris of aging.

The Bone Marrow Connection

Aging is often characterized by a decline in our body’s regenerative capacity. This decline starts in the bone marrow, where the hematopoietic stem cells (HSCs) responsible for creating our immune cells begin to falter. As we age, these cells become “myeloid-biased,” a shift that drives increased systemic inflammation and a weakened defense against chronic disease.

The study by Cai et al. (2026) demonstrates that periodic phlebotomy acts as a form of “hormetic stress”—a beneficial challenge that stimulates the bone marrow to restore its youthful function. This process leads to enhanced neurogenesis, which improves learning and memory, and a significant reduction in the Senescence-Associated Secretory Phenotype (SASP). SASP is essentially the inflammatory “exhaust” that old cells emit, which can damage neighboring healthy tissues. Furthermore, researchers observed tangible tissue revitalization, including visible improvements in muscle mass, bone density, and skin thickness.

Why Functional Medicine is Different

Many patients ask, “How can I live longer and healthier?” Conventional medicine often waits for an organ to fail or a clear pathology to emerge before intervening. In contrast, longevity medicine at CorAeon focuses on preventive health. We analyze the systemic environment—the blood, the marrow, and the signaling molecules—to intervene long before chronic disease takes hold.

By utilizing integrative longevity care, we can incorporate innovative strategies like PTP alongside personalized nutrition and targeted supplementation. The 2026 study found that a bi-weekly schedule was most effective, providing the perfect balance between hematopoietic stimulation and recovery. This approach does not just manage symptoms; it restores the “youthful” signaling of your peripheral blood, allowing your liver, kidneys, and brain to function at their physiological peak.

CorAeon: Science-Backed Longevity

Our functional medicine practice, CorAeon, is built on the principle that your biological age does not have to match the number on your birth certificate. We leverage advanced diagnostics and the latest peer-reviewed research to offer you a pathway to a vibrant, active future. Whether it is through optimizing your hematopoietic health or addressing the underlying causes of systemic inflammation, we are your dedicated partners in this journey toward optimal wellness.

If you are ready to take control of your aging process and explore the cutting edge of root-cause medicine, we invite you to discover more at coraeon.com. True longevity is about more than just surviving; it is about thriving with the energy, clarity, and resilience of your younger self.

Start your journey toward a superior healthspan today. Visit us at coraeon.com to learn how our personalized, science-driven protocols can transform your future.

Aging Cell Received: 23 May 2025 | Revised: 19 January 2026 | Accepted: 24 January 2026

The study, a comprehensive meta-analysis of over 600 participants, explores how our internal biological clocks—our circadian rhythms—interact with exercise to influence cardiometabolic health. The findings suggest that for those looking to optimize blood pressure and blood sugar, the clock on the wall may be just as important as the miles on the treadmill.

The Circadian Connection: Why Timing Matters

Every cell in your body operates on a 24-hour molecular clock. These rhythms regulate everything from hormone secretion to cardiac function. In longevity medicine, we recognize that modern life—artificial lights, late-night snacking, and sedentary habits—often pushes these clocks out of sync, contributing to metabolic disease and accelerated aging.

Exercise acts as a “zeitgeber” (a time-giver), essentially a signal that can help reset these internal clocks. However, the new research suggests that our body’s receptivity to this signal changes throughout the day.

The Afternoon Advantage for Heart Health

For decades, the “early bird” workout has been praised as the pinnacle of discipline. However, this recent meta-analysis reveals a different story for your arteries.

• Blood Pressure Mastery: The study found that Afternoon/Evening Exercise (PmEx) resulted in significantly lower blood pressure compared to morning sessions. Specifically, PmEx showed greater reductions in systolic, diastolic, and mean arterial blood pressure.

• The Adrenaline Factor: In the morning, our bodies experience a sharp rise in adrenaline and cortisol to wake us up. This can cause vasoconstriction and higher systemic vascular resistance. By exercising later in the day, when these hormones have stabilized, we may achieve a superior “hypotensive effect”—a natural lowering of blood pressure that persists long after the workout ends.

Metabolic Optimization: A Win for Blood Sugar

For individuals managing Type 2 Diabetes or metabolic syndrome, the timing of physical activity is a powerful lever for personalized healthcare.

The research highlighted that afternoon exercise training elicited a greater “hypoglycemic” (blood sugar lowering) response in clinical populations compared to morning exercise. This is likely because late-day movement enhances insulin sensitivity at a time when it naturally begins to dip, preventing the “evening spike” in glucose and free fatty acids that can damage tissues over time.

The CorAeon Perspective: Adherence Over All

While the data leans toward the afternoon for peak cardiometabolic benefits, at CorAeon, we emphasize that the best time to exercise is the time you will actually do it. A “perfect” 5:00 PM workout is useless if your work schedule makes it impossible to maintain. Preventive health is built on consistency. If you are a natural “morning person,” forcing yourself into an evening routine might decrease your enjoyment and, ultimately, your adherence.

Key Takeaways for Your Routine:

1. For Blood Pressure: If you struggle with hypertension, consider moving your primary aerobic session to the late afternoon or early evening.

2. For Metabolic Health: If you are focused on glucose control, an afternoon walk or cycling session may provide the most “bang for your buck” in stabilizing blood sugar.

3. Listen to Your Chronotype: Your “internal bird”—whether you are an owl or a lark—matters. Aligning your most intense efforts with your natural peak energy levels is a cornerstone of functional medicine.

At CorAeon, we are dedicated to using the latest peer-reviewed insights to refine your path to a longer, more vibrant life. Whether it’s through hormone optimization or fine-tuning your metabolic triggers, we are here to help you master your biology.

Ready to dive deeper into your personalized health data? Visit coraeon.com to explore our advanced diagnostic panels and longevity coaching.

In Health, The CorAeon Team

Journal of Sports Sciences, 1–31. https://doi.org/10.1080/02640414.2026.2637042

The concerns about the Ez-PAVE trial are scientifically reasonable and highlight important nuances in interpreting lipid-lowering data. The trial showed a 33% relative risk reduction (3.1% absolute risk reduction) with intensive LDL targeting (<55 mg/dL vs <70 mg/dL), but several factors warrant careful consideration before generalizing these results.

Population-specific considerations are valid. The trial was conducted exclusively in East Asian patients in South Korea, and the authors themselves acknowledged this as a limitation, noting that “racial or ethnic disparities in cardiovascular risk warrant consideration.” While previous trials in East Asian populations have shown results consistent with expected effects of LDL-lowering therapies, certain Asian populations may have greater responses to certain statins. Caution about generalizing to other populations, particularly women, is supported by the data.

The sex difference observation merits attention. The benefit appears driven primarily by men, with a hazard ratio of 1.22 in women showing no clear benefit. This is particularly important given that large meta-analyses have demonstrated that statin therapy produces similar proportional reductions in cardiovascular events in both sexes when adjusted for baseline risk. The lack of benefit in women in Ez-PAVE contrasts with this established evidence and suggests either a statistical artifact from the small female sample size or a population-specific phenomenon requiring further investigation.

The magnitude of effect relative to LDL reduction is noteworthy. The ~10 mg/dL difference in achieved LDL-C (56 vs 66 mg/dL) producing a 3.1% absolute risk reduction is indeed a large effect size. Meta-analyses have established that each 1 mmol/L (38.7 mg/dL) reduction in LDL-C is associated with approximately 23% relative risk reduction in major vascular events. The Ez-PAVE results suggest a steeper dose-response relationship at these lower LDL levels, which could reflect threshold effects, pleiotropic benefits of the therapies used, or population-specific factors.

Pleiotropic effects beyond LDL lowering are well-documented. Ezetimibe and other lipid-lowering agents have effects beyond LDL reduction. Ezetimibe has demonstrated anti-inflammatory, anti-atherogenic, and antioxidant properties, as well as potential benefits for insulin sensitivity and liver function. These off-target effects may contribute to cardiovascular benefit independent of LDL lowering, making this “more than a ‘lower LDL is better’ story,” as the author states.

The relationship between absolute LDL reduction and cardiovascular benefit is well-established but complex. Multiple meta-analyses confirm that absolute LDL-C reduction (not just percentage reduction) accounts for the majority of between-study variability in cardiovascular event reduction—98% in one major analysis. However, the benefit also depends on baseline risk and baseline LDL-C levels, meaning individual patient characteristics matter significantly.

Nuance is appropriate. The Ez-PAVE trial provides valuable data supporting intensive LDL lowering in high-risk patients with established cardiovascular disease, but the results should not be reflexively applied to all populations without considering individual patient factors including sex, ethnicity, baseline risk, and potential for both beneficial and adverse pleiotropic effects.

The 2026 ACC/AHA guidelines on dyslipidemia management acknowledge that while intensive LDL lowering provides benefit, treatment decisions should be individualized based on baseline risk, expected LDL reduction, and patient-specific factors. The evidence supports treating to lower LDL targets in high-risk patients, but the author’s emphasis on precision medicine and independent thinking aligns with contemporary guideline recommendations for shared decision-making.

At CorAeon, we move beyond the superficial “eight hours a night” advice. As a premier functional medicine practice, our mission is to decode the root cause of health challenges. We understand that longevity medicine is not just about adding years to your life, but about expanding your healthspan—the period of life spent in optimal wellness, free from the burden of chronic disease. When it comes to your heart, sleep is where the repair work happens.

The Multidimensionality of Rest

Modern research, including large-scale studies from the UK Biobank and the All of Us Research Program, reveals that sleep is multidimensional. It is not just about duration; it is about regularity, timing, and architecture. Functional medicine emphasizes that our bodies operate on a delicate circadian rhythm. When this rhythm is disrupted, it triggers a cascade of inflammatory signals.

Data shows a clear “J-shaped” relationship between sleep and heart health. While short sleep—defined as less than seven hours—is strongly linked to hypertension and obesity, excessively long sleep can also be a marker of underlying systemic dysfunction. However, the emerging frontier in preventive health is sleep regularity. Even if you get enough total hours, shifting your bedtime and wake time by more than two hours can increase your risk of atherosclerosis and metabolic distress. This is why CorAeon practitioners emphasize consistency as a non-negotiable component of integrative longevity care.

How Functional Medicine Addresses the Root Cause

Conventional medicine often treats sleep as an afterthought or manages insomnia with a prescription. At CorAeon, we look deeper. We ask: Is your poor sleep caused by a cortisol imbalance? Is it a symptom of silent systemic inflammation? Or perhaps it is related to nutrient deficiencies that govern your neurotransmitters? By addressing these root causes, we don’t just help you sleep; we help your heart heal.

The integration of digital health technologies allows us to monitor sleep architecture—the specific stages like deep sleep and REM. Emerging evidence suggests that deep sleep is particularly protective against atrial fibrillation and stroke because it modulates the autonomic nervous system’s signaling to the heart. This science-backed approach is what defines CorAeon as a leader in longevity medicine. We utilize data from wearable devices and advanced biomarkers to create a personalized blueprint for your health.

Your Path to Optimal Wellness

True longevity is a proactive choice. If you are ready to stop guessing and start optimizing, our team is here to guide you through a comprehensive evaluation of your cardiovascular and metabolic health. We believe that everyone deserves a life characterized by vitality and resilience. By mastering the fundamentals of rest and root-cause medicine, you can protect your heart for decades to come.

Take the first step toward a longer, more vibrant life by visiting us at coraeon.com to explore our unique approach to preventive health. Whether you are struggling with fatigue or looking to refine an already healthy lifestyle, we provide the expert, warm, and science-driven care you need to thrive.

Don’t leave your healthspan to chance. Discover the difference that personalized, integrative longevity care can make. Schedule your consultation today at coraeon.com.

Arterioscler Thromb Vasc Biol. 2026;46:e322869.

A landmark meta-analysis recently published by Li and Zhang (2026) offers a definitive, evidence-based roadmap for managing this stress. By synthesizing data from 41 randomized controlled trials conducted between 2011 and 2025, the researchers have confirmed that Omega-3 polyunsaturated fatty acids (PUFAs) are not just “heart-healthy” fats—they are powerful tools for functional recovery.

The Science of Soreness: Key Findings

The study utilized the PRISMA 2020 criteria to evaluate the impact of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on primary markers of muscle injury and systemic inflammation.

1. Significant Reduction in Inflammatory Markers

The meta-analysis found consistent, moderate reductions in several high-priority biomarkers:

• Interleukin-6 (IL-6) & Tumor Necrosis Factor-α (TNF-α): These pro-inflammatory cytokines were significantly attenuated, suggesting that Omega-3s help “cool” the systemic inflammatory fire after high-intensity bouts.

• Creatine Kinase (CK): Often used as the gold standard for measuring muscle cell membrane rupture, CK levels were notably lower in participants supplementing with Omega-3s.

• Delayed-Onset Muscle Soreness (DOMS): Perhaps most importantly for the athlete’s experience, subjective reports of “the day after” soreness were significantly reduced.

2. The Power of “Specialized Pro-Resolving Mediators”

Mechanistically, the study highlights that Omega-3s don’t just “block” inflammation like an NSAID might. Instead, they provide the building blocks for Resolvins, Protectins, and Maresins. These molecules actively help the body resolve inflammation and initiate tissue repair, leading to a more efficient return to homeostasis.

Optimizing Your Protocol: Dose and Duration

Not all Omega-3 regimens are created equal. The meta-analysis identified specific “sweet spots” for maximum efficacy:

• The Dosage Threshold: The strongest effects were seen at doses of 2g per day or more of combined EPA and DHA.

• The Duration Requirement: Tissue incorporation takes time. A minimum of 6 weeks of consistent supplementation was required to see the most robust improvements in recovery kinetics.

• Target Population: Interestingly, recreational athletes showed greater responsiveness than elite athletes, likely because elite performers already have highly adapted anti-inflammatory systems.

CorAeon: Your Partner in Longevity and Performance

At CorAeon, our Functional Medicine Longevity Medical Practice integrates these cutting-edge nutritional insights into personalized health optimization plans. We understand that cardiovascular health and athletic recovery are two sides of the same coin. By stabilizing muscle cell membranes and enhancing antioxidant capacity through targeted Omega-3 protocols, we help our clients sustain long-term performance and metabolic health.

Whether you are a competitive athlete or someone looking to stay active well into your later years, our data-driven approach ensures your supplementation is backed by the latest science, such as the Li and Zhang meta-analysis.

Take the Next Step

Optimizing your fatty acid profile is a cornerstone of longevity medicine. To learn more about how we can tailor a recovery and longevity protocol for your specific needs, visit us at coraeon.com.

The FASEB Journal Received: 12 December 2025 | Revised: 31 January 2026 | Accepted: 10 March 2026

In the pursuit of longevity, we often focus on the visible signs of aging. However, recent breakthroughs in geroscience suggest that the most significant factor in how we age isn’t what we see in the mirror, but a silent, biological process occurring deep within our cells. This phenomenon is known as inflammaging.

What is Inflammaging?

The term “inflammaging” describes a state of chronic, low-grade, systemic inflammation that develops as we get older. Unlike the acute inflammation you experience when healing a broken bone or fighting a cold, inflammaging is “sterile”—meaning it persists even in the absence of an active infection.

This persistent immune activation acts like “biological background noise,” slowly degrading tissue function and driving the development of age-related conditions, including cardiovascular disease, neurodegeneration, and metabolic decline.

The Mechanisms: Why Does It Happen?

According to a recent workshop report from the National Institutes of Health (NIH), inflammaging is driven by several interconnected cellular failures:

• Mitochondrial Dysfunction: As we age, the “power plants” of our cells—the mitochondria—lose their ability to manage calcium properly. This leakiness triggers inflammatory signals and cripples the cell’s ability to defend itself against pathogens.

• Cellular Senescence: Some cells stop dividing but refuse to die. These “zombie cells” develop a Senescence-Associated Secretory Phenotype (SASP), pumping out proinflammatory cytokines that “infect” neighboring healthy cells with inflammation.

• Genomic Instability: Damage to our DNA can lead to the accumulation of genetic material in the cytoplasm of the cell. The immune system mistakes this internal debris for a viral invader, triggering a permanent “red alert” status.

Emerging Intervention Strategies

The good news is that inflammaging is no longer considered an inevitable slide toward decay. Researchers are identifying specific “checkpoints” where we can intervene to restore youthful immune function.

1. Senolytics and Targeted Therapy

New drug classes called senolytics (such as the combination of Dasatinib and Quercetin) are being studied for their ability to selectively clear out senescent “zombie” cells. In animal models, these interventions have shown promise in reducing arterial stiffness and improving metabolic health.

2. Metabolic Reprogramming

The CALERIE-II trials highlighted the power of nutrient sensing. Calorie restriction—and the subsequent “browning” of white adipose tissue—can rewire metabolic pathways to protect against systemic inflammation. Similarly, boosting NAD+ levels can activate sirtuins (like SIRT2), which act as natural “brakes” on the inflammatory response.

3. The Gut-Immune Axis

Our microbiome plays a massive role in regulating “immune tone.” Strategies to reduce “leaky gut”—such as targeted probiotics or even fecal microbiota transplantation—are being explored to prevent gut-derived toxins from entering the bloodstream and fueling systemic fire.

The CorAeon Approach to Longevity

At CorAeon, we believe that understanding these complex biological markers is the first step toward true longevity. As a physician-led functional medicine and longevity practice, we specialize in the deep connection between the heart and the mind.

Inflammaging doesn’t just affect your joints; it affects your vascular elasticity and your cognitive clarity. We utilize advanced diagnostic testing—including comprehensive biomarker panels—to identify your specific drivers of inflammation. By combining cutting-edge science with grounded Mediterranean lifestyle strategies, we help you lower your “biological age” and optimize your healthspan.

To learn more about how we can help you navigate the science of aging, visit us at coraeon.com.

The preponderance of evidence suggests that higher processed meat consumption increases dementia risk, while the relationship with unprocessed meat is complex and may vary by APOE genotype. The article discusses a single 2026 Swedish study showing protective effects of meat in APOE4 carriers, but this finding must be contextualized within the broader literature showing predominantly harmful associations with processed meat and benefits from plant-based dietary patterns. [1-3]

The Broader Evidence on Meat and Dementia

Multiple large prospective studies demonstrate that processed meat consumption increases dementia risk. A 2025 analysis of 133,771 US adults followed for up to 43 years found that processed red meat intake ≥0.25 servings/day was associated with a 13% higher dementia risk (HR 1.13, 95% CI 1.08-1.19) and 14% higher risk of subjective cognitive decline (RR 1.14, 95% CI 1.04-1.25) compared to <0.10 servings/day. [1] Each additional serving per day of processed meat accelerated cognitive aging by 1.61 years for global cognition and 1.69 years for verbal memory. [1]

A meta-analysis of 24 prospective cohort studies involving over 500,000 participants found that total processed meat consumption increased neurodegenerative cognitive impairment risk by 67% (RR 1.67, 95% CI 1.46-1.92), while processed red meat increased risk by 22% (RR 1.22, 95% CI 1.11-1.34). [3] Each additional 50g/day of processed meat increased NCI risk by 12% (RR 1.12, 95% CI 1.08-1.17). [3]

The UK Biobank study of 493,888 participants found that each additional 25g/day of processed meat was associated with 44% increased all-cause dementia risk (HR 1.44, 95% CI 1.24-1.67) and 52% increased Alzheimer’s disease risk (HR 1.52, 95% CI 1.18-1.96). [2]

The Unprocessed Meat Paradox

The relationship with unprocessed meat is more nuanced. The same UK Biobank study found that 50g/day increment in unprocessed red meat was associated with reduced dementia risk (HR 0.81, 95% CI 0.69-0.95) and reduced AD risk (HR 0.70, 95% CI 0.53-0.92). [2] A French study found that very low meat consumption (≤1 time/week) was associated with increased dementia risk (HR 1.58, 95% CI 1.17-2.14) compared to regular consumption (≥4 times/week). [4]

These findings suggest a potential U-shaped relationship where both very low and very high (particularly processed) meat consumption may be problematic.

APOE4 Genotype Interactions

The 2026 Swedish study cited in the article is indeed novel in demonstrating APOE-specific effects. [5] Among 2,157 older adults, higher total meat consumption was associated with better cognitive trajectories (β = 0.32, 95% CI 0.07-0.56) and reduced dementia risk (sHR 0.45, 95% CI 0.21-0.95) only in APOE ε3/ε4 and ε4/ε4 carriers, with no associations in non-carriers. [5]

Importantly, the study found that a higher ratio of processed to total meat was unfavorably associated with dementia (sHR 1.14, 95% CI 1.01-1.29) regardless of APOE status, with no substantial difference between unprocessed red meat and poultry. [5] This suggests the benefit was driven by unprocessed meat, not processed meat.

The authors note this aligns with “underappreciated patterns” in the UK Biobank, where unprocessed red meat’s inverse association with dementia was driven by APOE4 carriers (HR 0.64 per 50g/day, P<0.001) with no association in non-carriers (HR 0.93, P=0.59). [5]

Dietary Patterns Provide Stronger Evidence

The most robust evidence supports plant-based dietary patterns like the Mediterranean and MIND diets for dementia prevention. A 2025 meta-analysis found that Mediterranean diet adherence was associated with 11-30% reduction in risk of cognitive impairment, dementia, and Alzheimer’s disease. [6] The Mediterranean diet is characterized by high consumption of fruits, vegetables, whole grains, fish, and olive oil with low to moderate meat intake. [7-8]

Figure 3. A Heat Map Showing the Associations of Average Food Group Intake With Cognitive Outcomes and Their Correlations With Dietary Pattern Scores

Dietary Patterns and Indicators of Cognitive Function. JAMA Neurol. February 22, 2026.

Content used under license from the JAMA Network®
© American Medical Association

This heat map from a 2026 study of dietary patterns and cognitive function demonstrates that red and processed meats consistently show unfavorable associations (red coloring) with cognitive outcomes across multiple healthy dietary patterns, while vegetables, fish, and plant foods show favorable associations (green coloring). [9]

The MIND diet, which specifically emphasizes green leafy vegetables and berries while limiting red meat, showed particularly strong associations with cognitive protection. [7][10] A 2025 analysis across five racial/ethnic groups found that higher MIND diet scores were associated with 9% lower ADRD risk (HR 0.91, 95% CI 0.87-0.96), with dietary improvement over 10 years associated with 11-25% lower risk. [11]

Mechanisms: Why Processed Meat May Harm

Several mechanisms explain why processed meat may increase dementia risk:

Advanced glycation end products (AGEs) and nitrosamines in processed meats promote oxidative stress and inflammation. [3] Heme iron from red meat may contribute to oxidative damage. [1] Saturated fat content may promote vascular dysfunction and insulin resistance. [12]

The 2025 US study found that replacing one serving of processed meat with nuts and legumes was associated with 19% lower dementia risk (HR 0.81, 95% CI 0.75-0.86), 1.37 fewer years of cognitive aging, and 21% lower risk of subjective cognitive decline (RR 0.79, 95% CI 0.68-0.92). [1]

APOE4-Specific Considerations

The hypothesis that APOE4 carriers may benefit from higher meat intake is biologically plausible given APOE4’s role in lipid metabolism. [5] However, the evidence for dietary interventions in APOE4 carriers predominantly supports Mediterranean-style diets, not high meat consumption. [12-14]

A 2025 study integrating genetic, metabolomic, and dietary data found that Mediterranean diet adherence more effectively modulated dementia-related metabolites in APOE4 homozygotes, suggesting targeted prevention strategies. [13] A scoping review found that adherence to Mediterranean diet may reduce cognitive decline among APOE ε4 carriers, whereas diets high in saturated fats may be particularly harmful for this group. [12]

Figure 2. Joint Effect Analysis of Cardiometabolic Disease (CMD) Status and Dietary Inflammatory Potential in Dementia Risk, Time to Dementia Diagnosis, and Brain Structural Differences

Anti-Inflammatory Diet and Dementia in Older Adults With Cardiometabolic Diseases. JAMA Netw Open. July 31, 2024.

Content used under license from the JAMA Network®
© American Medical Association

This figure demonstrates that among individuals with cardiometabolic diseases (which are more common in APOE4 carriers), following an anti-inflammatory diet compared to a proinflammatory diet is associated with substantially lower dementia risk and delayed time to dementia by approximately two years. [15]

A Swedish study found interactions between dietary patterns and APOE ε4 status: those with higher adherence to a healthy dietary pattern (vegetables, fruit, fish) had reduced dementia risk among ε4 non-carriers, while those with higher adherence to a western dietary pattern (red meat, refined cereals, full-fat dairy) had increased dementia risk among ε4 carriers (HR 1.37, 95% CI 1.05-1.78). [16]

Nutrients vs. Whole Foods

The article speculates about protective nutrients in meat (B12, creatine, taurine, carnosine). While these nutrients are important, the evidence supports obtaining them through diverse dietary sources rather than relying on high meat consumption. [17-18]

Omega-3 fatty acids from fish show consistent cognitive benefits. A meta-analysis found that dietary omega-3 intake could lower dementia risk by ~20%, with each 0.1g/day increment of DHA or EPA associated with 8-9.9% lower cognitive decline risk. [19]

Flavonoids from plant foods show robust protective effects. A 2024 UK Biobank analysis found that higher flavonoid intake was associated with 28% lower dementia risk (HR 0.72, 95% CI 0.57-0.89), with benefits from flavan-3-ols, flavonols, anthocyanins, and flavones. [20]

Table 2. Risk of Dementia by Quintiles of Flavodiet Score and Flavonoid Subclass Intake Among UK Biobank Participantsa

Flavonoid-Rich Foods, Dementia Risk, and Interactions With Genetic Risk, Hypertension, and Depression. JAMA Netw Open. September 2, 2024.

Content used under license from the JAMA Network®
© American Medical Association

B vitamins (folate, B6, B12) from diverse sources show protective effects. A 2024 study found that higher intake of one-carbon metabolism nutrients was associated with reduced AD risk, with participants with low genetic risk and high nutrient intake having >75% reduced AD risk. [18]

Limitations and Context

The Swedish study has important limitations:

1. Observational design with food frequency questionnaires subject to recall bias and residual confounding [5]

2. Relatively small sample of APOE4 carriers (569 participants, 26.4%) [5]

3. Contradicts larger studies showing harm from processed meat [1-3]

4. Cannot establish causation - the association may reflect other healthy behaviors in meat consumers

The authors themselves note this is “the first study to demonstrate interactions between meat consumption and APOE status” and acknowledge the need for replication. [5]

Clinical Recommendations

Current evidence-based guidelines for dementia prevention emphasize:

Plant-based dietary patterns (Mediterranean, DASH, MIND diets) with strong evidence for cognitive protection [7][10][21-22]

Limiting processed meat consumption given consistent associations with increased dementia risk [1-3]

Moderate fish consumption for omega-3 fatty acids [19]

Abundant vegetables, fruits, whole grains, legumes, and nuts [7][17][22]

The American Heart Association’s scientific statement on brain health recommends that “greater adherence to healthier diets such as the DASH, Mediterranean, and MIND diets are associated with slower cognitive decline in middle-aged and older adults.” [21]

Conclusion

While the 2026 Swedish study provides intriguing evidence for APOE4-specific effects of unprocessed meat, the preponderance of evidence supports limiting processed meat and emphasizing plant-based dietary patterns for dementia prevention. The finding that unprocessed meat may benefit APOE4 carriers requires replication in larger studies and does not contradict recommendations to limit processed meat, which shows consistent harm across genotypes.

For APOE4 carriers specifically, the strongest evidence supports Mediterranean-style diets that include moderate amounts of fish and may include modest amounts of unprocessed meat, rather than high meat consumption. [12-14][16] The critical distinction appears to be between processed and unprocessed meat, and between meat as part of an overall healthy dietary pattern versus meat as a predominant dietary component.

Would you like me to explore the specific mechanisms by which different dietary patterns may protect cognitive function in APOE4 carriers, or examine the evidence for other modifiable lifestyle factors in this high-risk population?

1.

Long-Term Intake of Red Meat in Relation to Dementia Risk and Cognitive Function in US Adults.

Neurology. 2025. Li Y, Li Y, Gu X, et al.

2.

Meat Consumption and Risk of Incident Dementia: Cohort Study of 493,888 UK Biobank Participants.

The American Journal of Clinical Nutrition. 2021. Zhang H, Greenwood DC, Risch HA, et al.

3.

Association of Dietary Meat Consumption Habits With Neurodegenerative Cognitive Impairment: An Updated Systematic Review and Dose-Response Meta-Analysis of 24 Prospective Cohort Studies.

Food & Function. 2022. Quan W, Xu Y, Luo J, et al.

4.

Intake of Meat, Fish, Fruits, and Vegetables and Long-Term Risk of Dementia and Alzheimer’s Disease.

Journal of Alzheimer’s Disease : JAD. 2019. Ngabirano L, Samieri C, Feart C, et al.

5.

Meat Consumption and Cognitive Health by APOE Genotype.

JAMA Network Open. 2026. Jakob Norgren, PhD, Adrián Carballo-Casla, PhD, Giulia Grande, MD, PhD, et al

6.

The Role of the Mediterranean Diet in Reducing the Risk of Cognitive Impairement, Dementia, and Alzheimer’s Disease: A Meta-Analysis.

GeroScience. 2025. Fekete M, Varga P, Ungvari Z, et al.New

7.

Nutrition and Prevention of Cognitive Impairment.

The Lancet. Neurology. 2018. Scarmeas N, Anastasiou CA, Yannakoulia M.

8.

Mediterranean Diet and Cognitive Function: From Methodology to Mechanisms of Action.

Free Radical Biology & Medicine. 2021. Siervo M, Shannon OM, Llewellyn DJ, Stephan BC, Fontana L.

9.

Dietary Patterns and Indicators of Cognitive Function.

JAMA Neurology. 2026. Chen H, Cortese M, Flores-Torres MH, et al.New

10.

The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) Diets Are Associated With Less Cognitive Decline and a Lower Risk of Alzheimer’s Disease-a Review.

Advances in Nutrition. 2019. van den Brink AC, Brouwer-Brolsma EM, Berendsen AAM, van de Rest O.

11.

Dietary Patterns and Risk of Alzheimer’s Disease and Related Dementias Across Five Racial and Ethnic Groups in the Multiethnic Cohort Study.

The American Journal of Clinical Nutrition. 2025. Park SY, Setiawan VW, Crimmins EM, et al.New

12.

A Scoping Review of Dietary Factors Conferring Risk or Protection for Cognitive Decline in APOE Ε4 Carriers.

The Journal of Nutrition, Health & Aging. 2021. Fote GM, Geller NR, Reyes-Ortiz AM, et al.

13.

Interplay of Genetic Predisposition, Plasma Metabolome and Mediterranean Diet in Dementia Risk and Cognitive Function.

Nature Medicine. 2025. Liu Y, Gu X, Li Y, et al.New

14.

APOE Ε4 and Dietary Patterns in Relation to Cognitive Function: An Umbrella Review of Systematic Reviews.

Nutrition Reviews. 2025. Urich TJ, Tsiknia AA, Ali N, et al.New

15.

Anti-Inflammatory Diet and Dementia in Older Adults With Cardiometabolic Diseases.

JAMA Network Open. 2024. Dove A, Dunk MM, Wang J, et al.

16.

Interactions Between Dietary Patterns and Genetic Factors in Relation to Incident Dementia Among 70-Year-Olds.

European Journal of Nutrition. 2022. Samuelsson J, Najar J, Wallengren O, et al.

17.

Dietary Components and Nutritional Strategies for Dementia Prevention in the Elderly.

Current Alzheimer Research. 2023. Cao XP, Xu W, Wang ZT, Tan L, Yu JT.

18.

Associations Among Dietary 1-Carbon Metabolism Nutrients, Genetic Risk, and Alzheimer Disease: A Prospective Cohort Study.

The American Journal of Clinical Nutrition. 2024. Wang Y, Mi N, Liao K, et al.

19.

The Relationship of Omega-3 Fatty Acids With Dementia and Cognitive Decline: Evidence From Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.

The American Journal of Clinical Nutrition. 2023. Wei BZ, Li L, Dong CW, Tan CC, Xu W.

20.

Flavonoid-Rich Foods, Dementia Risk, and Interactions With Genetic Risk, Hypertension, and Depression.

JAMA Network Open. 2024. Jennings A, Thompson AS, Tresserra-Rimbau A, et al.

21.

A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association.

Stroke. 2021. Lazar RM, Howard VJ, Kernan WN, et al.Guideline

22.

Nutrition for Dementia Prevention: A State of the Art Update for Clinicians.

Age and Ageing. 2024. Townsend R, Fairley A, Gregory S, et al.

In the world of modern nutrition, the convenience of "grab-and-go" meals often comes with a hidden biological cost. At CorAeon, we believe that true health requires a unified Mind-Body Approach. As the only Functional Medicine and Longevity practice founded by both a Functional Cardiologist and a Functional Psychiatrist, we specialize in the intersection of physical cardiovascular health and the neurological drives that influence our dietary choices.

Understanding the latest science is the first step toward reclaiming your vitality. This week, we are diving into groundbreaking data presented at ACC.26 in New Orleans and published in JACC: Advances, which sheds new light on how ultraprocessed foods (UPFs) are impacting our longevity.

🍔 The UPF Factor: More Than Just Calories

The Multiethnic Study of Atherosclerosis (MESA) recently tracked 6,814 adults over several years to determine how processed diets influence Atherosclerotic Cardiovascular Disease (ASCVD). Researchers utilized the NOVA classification system, which strips away traditional labels like "low fat" or "high carb" to focus on how much a food has been industrially altered.

The findings were stark: participants in the highest consumption group were 67% more likely to experience a fatal or nonfatal heart attack, stroke, or cardiac arrest compared to those who ate the least. Perhaps most surprisingly, lead author Dr. Amier Haidar noted that this risk persisted even after controlling for total calories, exercise, and pre-existing conditions like diabetes or high cholesterol. It isn’t just about "eating too much"; it’s about the inflammatory nature of the processed ingredients themselves.

📊 Addressing Health Inequities

The study revealed a troubling disparity in how these foods affect different communities. While every additional daily serving of UPFs increased cardiac risk by 5.1% overall, the impact was significantly amplified among Black Americans, who saw a 6.1% increase in risk per serving.

Researchers suggest this difference is likely driven by structural factors. Targeted marketing of low-quality foods to minority communities and "food deserts"—neighborhoods where fresh, unprocessed produce is inaccessible—create an environment where health outcomes are compromised by geography and socioeconomics rather than just personal choice.

🧠 The CorAeon Perspective: A Mind-Body Solution

At CorAeon, we look beyond the statistics. From a Functional Cardiology standpoint, UPFs trigger systemic inflammation and oxidative stress. From a Functional Psychiatry perspective, these foods are often engineered to hijack the brain’s reward system, making them difficult to quit despite the known risks.

Dr. Kim Allan Williams Sr. emphasizes that we need more than just willpower; we need structural solutions like transparent front-of-package labeling. Until those systemic changes arrive, the best defense is education and a personalized approach to wellness.

✅ What You Can Do Today

1. Read the Labels: If a food contains ingredients you wouldn't find in a home kitchen (emulsifiers, stabilizers, or artificial dyes), it is likely ultraprocessed.

2. The "Whole Food" Rule: Aim to transition just one UPF serving per day to a whole food alternative. That single shift could reduce your statistical cardiac risk by over 5%.

3. Partner with Experts: If you are struggling with cravings or cardiac concerns, our unique multidisciplinary team is here to help.

Visit us at coraeon.com to learn how our integrated approach can help you navigate the complexities of modern nutrition and cardiovascular longevity.

Maximum Heart Rate Estimation

The traditional formula (220 - age) has significant variability (±12 bpm) and should not be used in isolation.Sex-specific formulas provide more accurate estimates: 197 - 0.8 × age for women and 204 - 0.9 × age for men.

Preferably, maximum heart rate should be determined from formal exercise testing rather than age-predicted formulas

Target Heart Rate Zones by Population

Healthy adults: Moderate-intensity exercise corresponds to 64-76% of maximum heart rate (3-6 METs), while vigorous-intensity exercise corresponds to 77-93% of maximum heart rate (6-9 METs).The typical training range is 60-90% of maximum heart rate.

Patients with cardiovascular risk factors (hypertension, hyperlipidemia, obesity, diabetes with autonomic neuropathy): Target heart rate should be 55-79% of maximum heart rate, starting at 50-60% in those with low initial fitness and increasing as conditioning improves.

Cardiac patients: Heart rate reserve (HRR = maximum HR - resting HR) is the preferred method for exercise prescription. Moderate-intensity continuous training typically uses 50-70% HRR, while high-intensity interval training uses 80-90% HRR.[2][5] For heart failure patients specifically, moderate intensity is defined as 50-69% of target heart rate, and high intensity as 70% to

Safety Thresholds and Termination Criteria

Absolute contraindications to exercise testing include acute MI within 2 days, unstable angina, uncontrolled arrhythmias with hemodynamic compromise, symptomatic severe aortic stenosis, decompensated heart failure, and resting hypertension ≥200/110 mmHg.

Exercise testing should be terminated for: sustained ventricular tachycardia, second- or third-degree AV block, drop in systolic BP >10 mmHg with increasing workload when accompanied by ischemia, moderate-to-severe angina, severe hypertension (>250/125 mmHg), or signs of poor perfusion.

Practical Monitoring

The Borg Perceived Exertion Scale (6-20) provides a validated alternative to heart rate monitoring, with RPE 12-16 corresponding to 40-80% heart rate reserve. The "talk test"—the ability to speak comfortably during exercise—is a simple safety indicator. Beta-blockers significantly lower both incremental HR rise and maximum HR, limiting physiological interpretation.

A recent study published in Pregnancy Hypertension (2026) investigated the effects of EVOO on healthy women of reproductive age. The goal was to see if high-quality olive oil could improve heart function and reduce inflammation before a woman even becomes pregnant.

The Power of Phenols

Not all olive oils are created equal. The study specifically used EVOO high in oleic acid and phenols. Phenols are natural compounds that act as antioxidants, protecting your cells from damage. The researchers compared women who took 40 grams (about 3 tablespoons) of EVOO daily for eight weeks against a group using sunflower oil.

Key Findings: Metabolism and Inflammation

The results provide a fascinating look at how EVOO works within the body:

• Better Insulin Control: Women taking EVOO saw a significant reduction in fasting insulin. This is a major win for longevity, as lower insulin levels generally indicate better metabolic health and a lower risk for type 2 diabetes.

• Fighting Inflammation: The study tracked a specific protein called MCP-1, which is linked to inflammation in the blood vessels. In the EVOO group, a decrease in MCP-1 was directly tied to lower systolic blood pressure.

• A “Good” Rise in LDL? Interestingly, LDL (often called “bad” cholesterol) rose slightly. However, researchers noted that in EVOO drinkers, LDL particles often become larger and more resistant to oxidation. In the world of functional medicine, we know that oxidized LDL is the real danger to your arteries, not necessarily the total number.

Why This Matters for Longevity

For women planning a pregnancy, these findings are vital. Issues like preeclampsia and gestational diabetes often stem from “hidden” inflammation or stiff arteries that exist long before the first trimester. By incorporating high-phenolic EVOO into your daily routine, you aren’t just seasoning a salad—you are reinforcing your vascular system.

At CorAeon, we specialize in advanced cardiovascular diagnostics, such as Cleerly AI-QCT and ApoB testing, to look far beyond standard cholesterol panels. Understanding how your diet influences these biomarkers is the key to preventing disease decades before it starts.

Quick Tips for Choosing Your EVOO

To get the benefits seen in this study, look for:

1. “Extra Virgin” Label: Avoid “light” or “refined” blends.

2. Harvest Date: Freshness matters for phenol content.

3. Dark Glass Bottles: Light and heat destroy the healthy compounds.

Your journey to a longer, healthier life starts with the choices you make in your kitchen and the data you get from your doctor.

Ready to optimize your heart health? Visit us at coraeon.com to learn more about our functional longevity programs and how we can help you achieve peak wellness.

Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health 43 (2026) 101411

The Prognostic Value Evidence Is Robust

The article's central claim—that AI plaque quantification lacks outcomes evidence—is contradicted by substantial published data. Multiple large registries demonstrate that quantitative plaque burden independently predicts cardiovascular events beyond traditional risk scores, calcium scoring, and visual CCTA assessment.

The CONFIRM2 registry (1,916 patients) showed AI-based quantitative coronary CTA (AI-QCT) significantly improved risk stratification compared to CAD-RADS (AUC 0.81 vs 0.79) A 10-year follow-up study found patients with stage 3 plaque burden had 3-4 fold increased risk of major adverse cardiac events even after adjusting for clinical risk factors (adjusted HR 3.57-4.37).

A 2025 meta-analysis of advanced coronary CTA analyses demonstrated mean C-index of approximately 0.80 for predicting cardiovascular events, with quantitative plaque assessment showing incremental prognostic accuracy (ΔC-index ~0.10) compared to conventional models. Critically, plaque volume carried greater prognostic value than stenosis grade in patients with non-obstructive disease—precisely the population the article dismisses.

The Physics Critique Contains Valid Points But Misses Clinical Context

The article correctly identifies CCTA's spatial resolution limitations (~1mm vs 10-20 micrometers for OCT). However, this critique conflates tissue-level characterization with volumetric quantification—two distinct capabilities with different clinical utilities.

Head-to-head comparisons with NIRS-IVUS show CCTA demonstrates high sensitivity for detecting fibroatheromas and fibrocalcific plaques, though with limited capability for fibrotic plaques. Importantly, quantitative CTA analysis substantially outperforms visual assessment (AUC for identifying lipid-rich plaques significantly higher with quantitative vs qualitative approaches).

The correlation between CCTA and IVUS for total plaque volume is excellent (r=0.91-0.94), though the article correctly notes the low-attenuation plaque correlation is weaker. However, validation studies against NIRS demonstrate that CCTA-measured low-density noncalcified plaque correlates with actual cholesterol content (r=0.52-0.68 )

The SCOT-HEART Critique Is OverstatedWhile the article raises legitimate concerns about SCOT-HEART's endpoint change and ascertainment bias, it ignores the totality of evidence. The 2025 Lancet review notes CCTA is associated with reduction in MI or death in chronic chest pain compared to stress testing, with the mechanism being identification of plaque leading to preventive therapy intensification.

The article dismisses the medication mechanism as "implausible" based on PROMISE showing no benefit despite medication uptake. However, PROMISE compared CCTA to functional testing—both arms received guideline-directed therapy based on their respective test results. SCOT-HEART added CCTA on top of standard care, a fundamentally different design that the article acknowledges but then dismisses.

The PCSK9 Inhibitor Argument Misrepresents the Evidence

The article correctly notes PCSK9 inhibitors show modest absolute risk reductions in secondary prevention (1.5% over 2-3 years, NNT ~60-70). However, it extrapolates inappropriately to non-obstructive disease populations without acknowledging:

1. No randomized trials exist testing PCSK9 inhibitors specifically in non-obstructive CAD identified by plaque quantification

2. The recently published VESALIUS-CV trial showed evolocumab benefit in patients without prior MI/stroke (median 4.6-year follow-up), with magnitude of benefit consistent with statin meta-analyses when normalized to LDL reduction.

3. Subgroup analyses show greater absolute benefit in higher-risk patients—exactly what plaque quantification aims to identify.

The article's claim that plaque quantification drives "unnecessary" PCSK9 use ignores that current guidelines already recommend PCSK9 inhibitors for high-risk patients on maximally tolerated statins. Plaque quantification may improve patient selection rather than expand inappropriate use.

The Reimbursement and Conflict-of-Interest Concerns Are Valid

The article's strongest arguments concern the reimbursement process. The establishment of Category I CPT codes before randomized outcomes trials is a legitimate systemic concern that extends beyond this specific technology. The financial relationships between industry, professional societies, and guideline authors represent structural conflicts that warrant scrutiny.

However, the article implies these conflicts invalidate the underlying science, which is a logical fallacy. The prognostic data from CONFIRM2, the 10-year follow-up studies, and meta-analyses come from independent academic registries, not company-sponsored trials.

What Evidence Is Actually Missing

The article is correct that Gap 3 remains open: no randomized trial demonstrates that treatment intensification based on AI plaque quantification improves outcomes compared to standard risk-based therapy. The DECIDE registry showing 51% management change is hypothesis-generating, not definitive.

A properly designed trial would randomize patients with non-obstructive CAD to: (1) plaque-guided therapy intensification vs (2) standard guideline-based care, with hard cardiovascular endpoints. This trial does not exist. Until it does, the incremental value of the $950 add-on remains biologically plausible but clinically unproven for outcome modification.

Conclusion

The article presents a valuable critique of healthcare technology adoption processes but overstates the evidence gaps for plaque quantification's prognostic value while understating the limitations of current risk stratification. The physics constraints are real but don't negate clinical utility. The PCSK9 argument conflates different patient populations. The conflict-of-interest concerns are valid but don't invalidate independent registry data showing robust risk prediction.

The core unanswered question is whether acting on quantitative plaque data improves outcomes beyond current practice—a question requiring randomized trials that don't yet exist.

The study found that for older adults at risk for Alzheimer’s, simply increasing their daily step count acted as a shield against brain decline. You can learn more about our integrated approach to brain and vascular health at coraeon.com.

Beyond Memory: Stopping the “Tau” Tangles

Alzheimer’s disease is often driven by two proteins in the brain: amyloid and tau. Amyloid usually appears first, but it is the buildup of tau “tangles” that actually leads to memory loss and functional decline.

The study followed 296 older adults for up to 14 years. The results were clear:

• Physical activity didn’t lower amyloid levels, but it did something more important.

• In people with high amyloid, higher step counts were linked to much slower tau accumulation.

• Essentially, exercise helped prevent the “tangles” from spreading, which kept the participants’ minds sharper for years longer.

The “Sweet Spot”: How Many Steps Do You Really Need?

You might think you need to run marathons to see these benefits. However, the researchers discovered a curvilinear relationship, meaning there is a “plateau” where the benefits are most effective without needing extreme effort.

The study divided participants into four groups:

1. Inactive: Under 3,000 steps per day.

2. Low Activity: 3,001–5,000 steps per day.

3. Moderate Activity: 5,001–7,500 steps per day.

4. Active: Over 7,501 steps per day.

The data showed that moderate activity (5,000 to 7,500 steps) provided nearly the same brain-protecting benefits as the highly active group. For sedentary individuals, even moving from the “inactive” to the “low activity” group reduced cognitive decline by 40%.

Your Longevity Roadmap: Three Steps to Start Today

At CorAeon, we focus on modifiable risk factors. Physical inactivity is one of the most powerful levers you can pull to change your future health.

• Track Your Baseline: Use a simple pedometer or a wearable like the Fitbit Inspire 3 to see where you are starting.

• Aim for 6,000: If you are currently sedentary, don’t worry about 10,000 steps. Focus on hitting the 6,000-step mark consistently.

• Monitor Your Biomarkers: Exercise works best when combined with a clear picture of your internal health. We recommend regular screenings for vascular health, as what is good for your heart is almost always good for your brain.

The CorAeon Promise

Your brain’s destiny isn’t just in your genes—it’s in your daily habits. This research proves that movement is a form of medicine that can modify the very trajectory of Alzheimer’s disease.

Are you ready to build a personalized plan for your long-term cognitive health? At CorAeon, the Functional Longevity Practice, we are here to help you navigate the science of living better, longer.

Visit us today at coraeon.com.

Nature Medicine volume 31, pages4075–4083 (2025)

At CorAeon, the Functional Longevity Practice, we focus on the most aggressive, science-backed strategies to not just manage heart disease, but to potentially reverse its progression. A landmark 2022 study from the European Journal of Preventive Cardiology has provided the strongest evidence yet that High-Intensity Interval Training (HIIT) can do exactly that.

You can learn more about our personalized longevity protocols at coraeon.com.

The Study: Shrinking the “Atheroma”

Researchers took 60 patients who had recently undergone heart procedures (PCI) and split them into two groups. One group followed standard health advice, while the other participated in supervised HIIT sessions twice a week for six months.

Using Intravascular Ultrasound (IVUS)—a tiny camera inside the artery—doctors measured the “Percent Atheroma Volume” (PAV), which is essentially the amount of space plaque takes up in the vessel wall.

The Results were game-changing:

• The HIIT Group: Experienced a significant reduction in plaque volume. Their arteries actually cleared out over the six-month period.

• The Control Group: Those following standard advice saw their plaque volume increase slightly or stay the same.

• Weight & Fitness: The HIIT group also saw a larger drop in waist circumference and a massive boost in their VO2peak (aerobic fitness), which is one of the strongest predictors of a long life.

Why Does HIIT Work Better?

You might wonder why “walking the dog” isn’t enough to see these results. The secret lies in Hemodynamic Forces.

When you perform high-intensity intervals (reaching 85–95% of your peak heart rate), your heart pumps blood with much greater force. This creates something called Endothelial Shear Stress. Think of this like a high-pressure wash for your arteries. This stress signals the artery lining to release protective chemicals that:

1. Stop Plaque Growth: It prevents new cholesterol from sticking to the walls.

2. Encourage Regression: It helps the body “clean up” existing fatty deposits.

3. Improve Vessel Flexibility: Your arteries become better at dilating and constricting.

Your CorAeon Action Plan: 4x4 Intervals

The specific protocol used in this successful study is known as the “Norwegian 4x4.” If you want to apply this science to your own routine, here is how to do it:

• Warm-up: 10 minutes of moderate activity (brisk walk or light jog).

• The Interval: 4 minutes of high-intensity effort. You should be breathing hard enough that you can only speak in short, clipped sentences.

• The Recovery: 3 minutes of very light movement to let your heart rate drop.

• Repeat: Do this four times total.

• Cool-down: 5 minutes of easy walking.

[!IMPORTANT] Because HIIT puts a high demand on the heart, it is essential to have a professional evaluation before starting. At CorAeon, we use advanced testing to ensure your “engine” is ready for high-performance training.

Beyond the Challenge

This research proves that your heart’s health isn’t fixed. With the right “dosage” of exercise, you can actively change the geometry of your arteries. At CorAeon, the Functional Longevity Practice, we are dedicated to helping you implement these high-impact habits safely and effectively.

Ready to take your cardiovascular health to the next level? Reach out to us at coraeon.com

European Journal of Preventive Cardiology (2023) 30, 384–392

A groundbreaking study published in Nature (2026) by Disouky and colleagues has provided some of the most definitive answers yet. By studying “SuperAgers”—individuals over 80 with the memory of people decades younger—and comparing them to those with Alzheimer’s disease, researchers have uncovered the “molecular signature” of a resilient brain.

At CorAeon, we are dedicated to applying this cutting-edge science to help you maintain cognitive vitality. Understanding how your brain regenerates is the first step toward a longer, sharper life.

The Discovery: A Path to New Neurons

The researchers used advanced “multiomic” sequencing to look at over 350,000 individual nuclei from human hippocampi (the brain’s memory center). They confirmed that even in adulthood, the brain contains Neural Stem Cells (NSCs).

These stem cells follow a specific “trajectory”:

1. NSCs: The “parent” cells that have the potential to become neurons.

2. Neuroblasts: The middle stage of development.

3. Immature Neurons: Newly formed cells that are just starting to plug into memory circuits.

4. Mature Granule Neurons: Fully integrated cells that power your thinking.

What Makes a “SuperAger”?

The study found that SuperAgers have a unique “resilience signature.” While people with Alzheimer’s showed a significant drop in immature neurons, SuperAgers actually had a 2.5-fold increase in these young, flexible cells compared to others their age.

More importantly, the researchers found that the environment of the brain matters. In healthy aging, cells called astrocytes and CA1 neurons maintain strong “excitatory synapse integrity.” Essentially, the wiring stays clean, allowing new neurons to thrive and communicate.

Why This Matters for Your Longevity

This research suggests that cognitive decline isn’t just about “losing” cells; it’s about the breakdown of the epigenetic “switches” that allow new cells to grow. The study identified that:

• Early Changes: Alterations in “chromatin accessibility” (how your DNA is packaged) happen long before symptoms of Alzheimer’s appear.

• Targeted Prevention: By focusing on synaptic plasticity and neurotransmission, we may be able to protect the neurogenic niche.

Flourish with CorAeon

At CorAeon, The Functional Longevity medical practice, we don’t just wait for age-related decline; we move to prevent it. We use the latest insights from functional medicine to optimize your brain’s “redox balance” and metabolic health—the very factors the Nature study highlights as essential for “successful aging.”

Whether you are interested in the Mediterranean diet’s impact on neurogenesis or high-performance protocols for brain health, we are here to guide you.

Find us at coraeon.com to learn more about our longevity programs.

Human hippocampal neurogenesis in adulthood, ageing and Alzheimer’s disease. Nature (2026). https://doi.org/10.1038/s41586-026-10169-4